Evidence map›Paper›PMID 35802628›Full record

Trial reportPloS one2022

Dementia risk and dynamic response to exercise: A non-randomized clinical trial.

Eric D Vidoni, Jill K Morris, Jacqueline A Palmer, Yanming Li, Dreu White, Paul J Kueck, Casey S John, Robyn A Honea, Rebecca J Lepping, Phil Lee and 3 more

Registry-linked trialOpen access · goldAbstract readClinical Trial
In one paragraph

Trial report in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04009629 (Dementia Risk and Dynamic Response to Exercise), which is not on this map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04009629 nacompletednot on this map

Dementia Risk and Dynamic Response to Exercise

TypeinterventionalSponsorUniversity of Kansas Medical CenterRan2019 to 2021Enrolled61ConditionsAlzheimer Disease 2 Due to Apoe4 Isoform, Healthy AgingArmsModerate Intensity Aerobic Exercise
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. BDNF-amyloid-Frontiers in molecular neuroscience · 2026
    Review
  3. Review
  4. Mitochondrial DNA affects tau phosphorylation in aging and Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Eric D VidoniDepartment of Neurology, University of Kansas Medical Center, Kansas City, KS, United States of America.ORCID 0000-0001-5181-7131
Jill K MorrisDepartment of Neurology, University of Kansas Medical Center, Kansas City, KS, United States of America.
Jacqueline A PalmerDepartment of Physical Therapy, Rehabilitation Science and Athletic Training, University of Kansas Medical Center, Kansas City, KS, United States of America.
Yanming LiDepartment of Biostatistics and Data Science, University of Kansas Medical Center, Kansas City, KS, United States of America.
Dreu WhiteDepartment of Physical Therapy, Rehabilitation Science and Athletic Training, University of Kansas Medical Center, Kansas City, KS, United States of America.
Paul J KueckDepartment of Neurology, University of Kansas Medical Center, Kansas City, KS, United States of America.ORCID 0000-0002-9102-2058
Casey S JohnDepartment of Neurology, University of Kansas Medical Center, Kansas City, KS, United States of America.
Robyn A HoneaDepartment of Neurology, University of Kansas Medical Center, Kansas City, KS, United States of America.
Rebecca J LeppingDepartment of Neurology, University of Kansas Medical Center, Kansas City, KS, United States of America.ORCID 0000-0001-9269-051X
Phil LeeDepartment of Radiology, University of Kansas Medical Center, Kansas City, KS, United States of America.
Jonathan D MahnkenDepartment of Biostatistics and Data Science, University of Kansas Medical Center, Kansas City, KS, United States of America.
Laura E MartinDepartment of Population Health, University of Kansas Medical Center, Kansas City, KS, United States of America.
Sandra A BillingerDepartment of Neurology, University of Kansas Medical Center, Kansas City, KS, United States of America.
University of Kansas Medical Center · US

Funding

RADx-UP: Improving the Response of Local Urban and Rural Communities to Disparities in Covid-19 TestingUL1TR002366 · NCATS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Mario Castro, JAMES STEVEN LEEDER · 2017 to 2026
$44.3M
University of Kansas Alzheimer's Disease Research Center (KU ADRC)P30AG072973 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Mohammad Haeri · 2021 to 2026
$25.3M
University of Kansas Alzheimer's Disease Core CentersP30AG035982 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI MAHNKEN, JONATHAN D · 2011 to 2020
$16.6M
Siemens Magnetom Verio MRI ScannerS10RR029577 · NCRR · UNIVERSITY OF KANSAS MEDICAL CENTER · PI BROOKS, WILLIAM M. · 2010 to 2010
$2.9M
Acute exercise and the cerebral metabolic response in aging and Alzheimer's DiseaseR01AG062548 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI MORRIS, JILL KATHLEEN · 2020 to 2024
$2.4M
Dementia Risk and Dynamic Response to ExerciseR21AG061548 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI VIDONI, ERIC DENNIS · 2019 to 2020
$383k
NCATS NIH HHS UL1 TR002366NCRR NIH HHS S10 RR029577NIA NIH HHS P30 AG035982NIA NIH HHS P30 AG072973NIA NIH HHS R21 AG061548
6 · The paper itself

Abstract

backgroundPhysical exercise may support brain health and cognition over the course of typical aging. The goal of this nonrandomized clinical trial was to examine the effect of an acute bout of aerobic exercise on brain blood flow and blood neurotrophic factors associated with exercise response and brain function in older adults with and without possession of the Apolipoprotein epsilon 4 (APOE4) allele, a genetic risk factor for developing Alzheimer's. We hypothesized that older adult APOE4 carriers would have lower cerebral blood flow regulation and would demonstrate blunted neurotrophic response to exercise compared to noncarriers.

methodsSixty-two older adults (73±5 years old, 41 female [67%]) consented to this prospectively enrolling clinical trial, utilizing a single arm, single visit, experimental design, with post-hoc assessment of difference in outcomes based on APOE4 carriership. All participants completed a single 15-minute bout of moderate-intensity aerobic exercise. The primary outcome measure was change in cortical gray matter cerebral blood flow in cortical gray matter measured by magnetic resonance imaging (MRI) arterial spin labeling (ASL), defined as the total perfusion (area under the curve, AUC) following exercise. Secondary outcomes were changes in blood neurotrophin concentrations of insulin-like growth factor-1 (IGF-1), vascular endothelial growth factor (VEGF), and brain derived neurotrophic factor (BDNF).

resultsGenotyping failed in one individual (n = 23 APOE4 carriers and n = 38 APOE4 non-carriers) and two participants could not complete primary outcome testing. Cerebral blood flow AUC increased immediately following exercise, regardless of APOE4 carrier status. In an exploratory regional analyses, we found that cerebral blood flow increased in hippocampal brain regions, while showing no change in cerebellum across both groups. Among high inter-individual variability, there were no significant changes in any of the 3 neurotrophic factors for either group immediately following exercise.

conclusionsOur findings show that both APOE4 carriers and non-carriers show similar effects of exercise-induced increases in cerebral blood flow and neurotrophic response to acute aerobic exercise. Our results provide further evidence that acute exercise-induced increases in cerebral blood flow may be regional specific, and that exercise-induced neurotrophin release may show a differential effect in the aging cardiovascular system. Results from this study provide an initial characterization of the acute brain blood flow and neurotrophin responses to a bout of exercise in older adults with and without this known risk allele for cardiovascular disease and Alzheimer's disease.

trial registrationDementia Risk and Dynamic Response to Exercise (DYNAMIC); Identifier: NCT04009629.

Indexed as

Alzheimer DiseaseApolipoprotein E4ExerciseAgedBrainFemaleHumansMaleApolipoprotein E4

Identifiers

PMID35802628
PMCPMC9269742
OpenAlexW4284962651

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.